Logo image of DEX.DE

DELTICOM AG (DEX.DE) Stock Fundamental Analysis

FRA:DEX - Deutsche Boerse Ag - DE0005146807 - Common Stock - Currency: EUR

2.32  +0.02 (+0.87%)

Fundamental Rating

5

DEX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Specialty Retail industry. While DEX has a great profitability rating, there are quite some concerns on its financial health. DEX is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year DEX was profitable.
DEX had a positive operating cash flow in the past year.
Of the past 5 years DEX 4 years were profitable.
In multiple years DEX reported negative operating cash flow during the last 5 years.
DEX.DE Yearly Net Income VS EBIT VS OCF VS FCFDEX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

With a decent Return On Assets value of 3.44%, DEX is doing good in the industry, outperforming 71.70% of the companies in the same industry.
With an excellent Return On Equity value of 16.71%, DEX belongs to the best of the industry, outperforming 83.02% of the companies in the same industry.
The Return On Invested Capital of DEX (14.13%) is better than 86.79% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DEX is above the industry average of 9.99%.
The 3 year average ROIC (13.71%) for DEX is below the current ROIC(14.13%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.44%
ROE 16.71%
ROIC 14.13%
ROA(3y)2.91%
ROA(5y)-1.69%
ROE(3y)14.06%
ROE(5y)-74.82%
ROIC(3y)13.71%
ROIC(5y)N/A
DEX.DE Yearly ROA, ROE, ROICDEX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

Looking at the Profit Margin, with a value of 1.60%, DEX is in the better half of the industry, outperforming 66.04% of the companies in the same industry.
DEX's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 3.23%, DEX is doing good in the industry, outperforming 64.15% of the companies in the same industry.
DEX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 28.50%, DEX is doing worse than 60.38% of the companies in the same industry.
In the last couple of years the Gross Margin of DEX has grown nicely.
Industry RankSector Rank
OM 3.23%
PM (TTM) 1.6%
GM 28.5%
OM growth 3Y1.64%
OM growth 5Y38.53%
PM growth 3Y10.82%
PM growth 5YN/A
GM growth 3Y1.63%
GM growth 5Y1.75%
DEX.DE Yearly Profit, Operating, Gross MarginsDEX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

3

2. Health

2.1 Basic Checks

DEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
DEX has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DEX has been increased compared to 5 years ago.
The debt/assets ratio for DEX has been reduced compared to a year ago.
DEX.DE Yearly Shares OutstandingDEX.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
DEX.DE Yearly Total Debt VS Total AssetsDEX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.50 indicates that DEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.50, DEX is in the better half of the industry, outperforming 71.70% of the companies in the same industry.
DEX has a debt to FCF ratio of 13.08. This is a negative value and a sign of low solvency as DEX would need 13.08 years to pay back of all of its debts.
DEX's Debt to FCF ratio of 13.08 is in line compared to the rest of the industry. DEX outperforms 47.17% of its industry peers.
A Debt/Equity ratio of 1.00 is on the high side and indicates that DEX has dependencies on debt financing.
DEX has a worse Debt to Equity ratio (1.00) than 71.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 13.08
Altman-Z 2.5
ROIC/WACC2.73
WACC5.18%
DEX.DE Yearly LT Debt VS Equity VS FCFDEX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

DEX has a Current Ratio of 0.89. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
DEX has a Current ratio of 0.89. This is in the lower half of the industry: DEX underperforms 79.25% of its industry peers.
DEX has a Quick Ratio of 0.89. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
DEX's Quick ratio of 0.30 is on the low side compared to the rest of the industry. DEX is outperformed by 79.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.3
DEX.DE Yearly Current Assets VS Current LiabilitesDEX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 185.45% over the past year.
DEX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.27% yearly.
DEX shows a decrease in Revenue. In the last year, the revenue decreased by -7.37%.
DEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.96% yearly.
EPS 1Y (TTM)185.45%
EPS 3Y0.27%
EPS 5YN/A
EPS Q2Q%-96.06%
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y-4.33%
Revenue growth 5Y-5.96%
Sales Q2Q%3.4%

3.2 Future

Based on estimates for the next years, DEX will show a very strong growth in Earnings Per Share. The EPS will grow by 42.03% on average per year.
Based on estimates for the next years, DEX will show a small growth in Revenue. The Revenue will grow by 2.18% on average per year.
EPS Next Y56.76%
EPS Next 2Y48.87%
EPS Next 3Y42.03%
EPS Next 5YN/A
Revenue Next Year-4.32%
Revenue Next 2Y-0.76%
Revenue Next 3Y0.6%
Revenue Next 5Y2.18%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DEX.DE Yearly Revenue VS EstimatesDEX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
DEX.DE Yearly EPS VS EstimatesDEX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.30, the valuation of DEX can be described as very cheap.
DEX's Price/Earnings ratio is rather cheap when compared to the industry. DEX is cheaper than 98.11% of the companies in the same industry.
DEX is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 5.60, the valuation of DEX can be described as very cheap.
Based on the Price/Forward Earnings ratio, DEX is valued cheaper than 90.57% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, DEX is valued rather cheaply.
Industry RankSector Rank
PE 4.3
Fwd PE 5.6
DEX.DE Price Earnings VS Forward Price EarningsDEX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DEX is valued cheaply inside the industry as 83.02% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, DEX is valued a bit cheaper than the industry average as 75.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.87
EV/EBITDA 4.02
DEX.DE Per share dataDEX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DEX may justify a higher PE ratio.
DEX's earnings are expected to grow with 42.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y48.87%
EPS Next 3Y42.03%

0

5. Dividend

5.1 Amount

DEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DELTICOM AG

FRA:DEX (3/7/2025, 7:00:00 PM)

2.32

+0.02 (+0.87%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-12 2024-11-12
Earnings (Next)03-27 2025-03-27/amc
Inst Owners22.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap34.41M
Analysts80
Price Target4.25 (83.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.83%
Valuation
Industry RankSector Rank
PE 4.3
Fwd PE 5.6
P/S 0.07
P/FCF 5.87
P/OCF 2.77
P/B 0.72
P/tB 3.15
EV/EBITDA 4.02
EPS(TTM)0.54
EY23.28%
EPS(NY)0.41
Fwd EY17.85%
FCF(TTM)0.4
FCFY17.04%
OCF(TTM)0.84
OCFY36.12%
SpS33.91
BVpS3.24
TBVpS0.74
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.44%
ROE 16.71%
ROCE 16.87%
ROIC 14.13%
ROICexc 14.69%
ROICexgc 24.51%
OM 3.23%
PM (TTM) 1.6%
GM 28.5%
FCFM 1.17%
ROA(3y)2.91%
ROA(5y)-1.69%
ROE(3y)14.06%
ROE(5y)-74.82%
ROIC(3y)13.71%
ROIC(5y)N/A
ROICexc(3y)14.55%
ROICexc(5y)N/A
ROICexgc(3y)25.91%
ROICexgc(5y)N/A
ROCE(3y)16.38%
ROCE(5y)N/A
ROICexcg growth 3Y-28.6%
ROICexcg growth 5YN/A
ROICexc growth 3Y-14.32%
ROICexc growth 5Y15.18%
OM growth 3Y1.64%
OM growth 5Y38.53%
PM growth 3Y10.82%
PM growth 5YN/A
GM growth 3Y1.63%
GM growth 5Y1.75%
F-Score7
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 13.08
Debt/EBITDA 1.8
Cap/Depr 62.59%
Cap/Sales 1.31%
Interest Coverage 6.53
Cash Conversion 46.49%
Profit Quality 73.04%
Current Ratio 0.89
Quick Ratio 0.3
Altman-Z 2.5
F-Score7
WACC5.18%
ROIC/WACC2.73
Cap/Depr(3y)32.35%
Cap/Depr(5y)26.39%
Cap/Sales(3y)0.59%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.45%
EPS 3Y0.27%
EPS 5YN/A
EPS Q2Q%-96.06%
EPS Next Y56.76%
EPS Next 2Y48.87%
EPS Next 3Y42.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y-4.33%
Revenue growth 5Y-5.96%
Sales Q2Q%3.4%
Revenue Next Year-4.32%
Revenue Next 2Y-0.76%
Revenue Next 3Y0.6%
Revenue Next 5Y2.18%
EBIT growth 1Y23.24%
EBIT growth 3Y-2.76%
EBIT growth 5Y30.27%
EBIT Next Year241.25%
EBIT Next 3Y63.6%
EBIT Next 5YN/A
FCF growth 1Y-76.08%
FCF growth 3Y-7.15%
FCF growth 5YN/A
OCF growth 1Y-52.76%
OCF growth 3Y-2.7%
OCF growth 5YN/A